Pharma CEOs Strike Collaborative Tone On Health Reform
Executive Summary
SAN ANTONIO - Collaboration with interest groups that rarely align on key health care issues and building a relationship with a reformist White House are two central strategies at the heart of the pharmaceutical industry's efforts to turn around its public image